VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

COSTEM 2019 | Total body irradiation vs. chemotherapy-based myeloablative conditioning for ASCT

Rainer Storb, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, elaborates on the most suitable method of myeloablative conditioning prior to allogeneic hematopoietic cell transplant (ASCT) for patients with myeloid malignancies. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter